The World Sarcoma Network will be officially presented within a satellite event of the CTOS Annual Event in New-York City on
October 30th, 2013 at 8:00pm.
This will be the opportunity for Industry and patient group representatives to have a wide and clear vision of the work perform the last 4 years by WSN Key Opinion Leaders worldwide to support and optimize in a pro-active manner the clinical research for sarcoma rare subtypes.
The SPAEN Annual Conference 2013 will be held from 10 to 12 October 2013 in London/UK.
The three day conference will focus on research, treatment and access to treatment and advocacy/capacity building. Leading European Sarcoma Experts and others will join us to present the latest medical news and answer your questions.
The program provides a big variety of lectures on the following topics including:
- Patient involvement in clinical research
- Adherence and side effect management
- Reimbursement and access to innovative drugs
- Parallel tracks for GIST, Sarcomas and Desmoids with medical updates on current treatment options and ongoing clinical trials
- Market place sessions
18th CTOS Annual Event – 30th Oct – 2nd Nov 2013 – Sheraton Madison Square, NYC-USA
The Connective Tissue Oncology Society was formed in 1995 and incorporated in 1997. CTOS is an international group comprised of physicians and scientists with a primary interest in the tumors of connective tissues. The goal of the society is to advance the care of patients with connective tissue tumors and to increase knowledge of all aspects of the biology of these tumors, including basic and clinical research.
CTOS organization and board of directors decided to set-up a symposium session dedicated to the Sarcoma of the Year focusing on Uterine Leiomyosarcoma Sarcoma. This session is labelled by the WSN.